Introduction
============

Early embryo death is considered to be one of the most important factors affecting fertility in cattle. For example, a previously conducted study found that, although the fertilization rate immediately following insemination of non-lactating beef cows was 100%, the survival rate of the embryos during days 14 to 16 was only 82.4% \[[@B17]\]. One of the factors that lead to early embryonic mortality in cows is a lower plasma progesterone (P~4~) concentration during the post insemination period \[[@B15]\]. Progesterone is involved in stimulation of a variety of endometrial secretions that are necessary for successful development of the embryo in the uterine lumen \[[@B10]\]. It has been reported that a suboptimum P~4~ concentration is correlated with the failure of embryo implantation and low fertility in cows \[[@B16]\]. However, it has been reported that bovine elongated embryos (well developed) are able to produce sufficient quantities of interferon-τ that are capable to prevent luteolytic PGF~2α~ secretion. Whereas poor developed embryos are associated with low interferon-τ production, failed inhibition of luteolysis and embryo loss \[[@B15]\]. Specifically, the production of interferon-τ by bovine embryos tended to be greater on day 18, when the P~4~ concentration had increased in response to the induction of an accessory corpus luteum (CL) \[[@B12]\]. In addition, the concentration of embryonic interferon-τ has been found to increase significantly on day 16 when progesterone was administered from days 5 to 9 \[[@B15]\]. Taken together, these findings indicate that increasing the P~4~ concentration by administering exogenous progesterone supplements using a controlled internal drug-release (CIDR) \[[@B7],[@B25]\] or progesterone releasing intravaginal device (PRID) \[[@B13],[@B29]\], or by feeding the animal progesterone \[[@B23],[@B25]\] may improve fertility and assist in the maintenance of pregnancy in cows. Furthermore, it is known that induction of ovulation and the consequent formation of an accessory CL following treatment with human chorionic gonadotropin (hCG) or gonadotropin releasing hormone (GnRH) at either day 5, 6, 11 or 14 of the estrous cycle will result in an increase in P~4~ concentration, thereby improving fertility \[[@B27]\]. Indeed, it has been reported that cows that have an additional accessory CL are 8.3 times less likely to experience fetal loss than cows that have only a single CL \[[@B14]\].

This study was conducted to evaluate the effects of injecting GnRH analogue on day 6 of the estrous cycle on the reproductive performance of Japanese black cows that were currently undergoing Ovsynch-based treatment. Specifically, the P~4~ profile and its relationship with the cross sectional area of the luteal tissue in non-inseminated cows, as well as the conception rate in artificially inseminated cows was evaluated.

Materials and Methods
=====================

Experiment 1
------------

[Fig. 1](#F1){ref-type="fig"} shows the protocol for this experiment. The goal of Experiment 1 was to examine the P~4~ profile and its relationship with the cross sectional area of luteal tissue in non-inseminated cows subjected to two different estrus synchronization programs. The animals used for Experiment 1 included 12 multiparous Japanese black cows that had lapsed approximately 40 days since their last parturition and had body condition scores (BCS; point scale from 1 to 5) \[[@B6]\] between 3.0 and 4.0. All animals were kept outdoors, fed hay and concentrate twice daily, and provided with water ad libitum.

The estrous cycles of the cows were synchronized by a single intramuscular injection of 500 µg of prostaglandin F~2α~ (PGF) analogue (Resipron-C; Teikoku Zoki, Japan), after which ovulation was confirmed by real-time ultrasonography (Aloka, Japan). When no ovulation was confirmed, the cows received a 2nd injection of PGF analogue 11 days after the 1st PGF analogue injection. Next, the 12 cows were randomly allocated to three experimental groups. In group 1 (Ovsynch + GnRH), the cows were synchronized with Ovsynch \[[@B20]\] and then injected with 100 µg of GnRH analogue (Buserelin; Teikoku Zoki, Japan) on day 6 (the 2nd GnRH analogue injection of Ovsynch was considered as day 0); In group 2 (Ovsynch + CIDR + GnRH), the cows were synchronized with Ovsynch + CIDR (Pfizer, Japan) and then injected with 100 µg of GnRH analogue on day 6. The remaining cows (the control) were synchronized with Ovsynch and then injected with physiological saline (placebo).

Blood samples were collected once a day before starting the ultrasonographical observation into heparinized tubes from the jugular vein of each animal and centrifuged at 1,670 g for 20 min at 4℃. The plasma samples were then stored at -20℃ until hormone analysis was performed. Double antibody radioimmunoassay was used to determine the concentrations of plasma P~4~ using antisera to progesterone (GDN\#337) \[[@B26]\], and the intra- and interassay coefficients for progesterone were found to be 4.2 and 8.0%, respectively.

To monitor the growth and regression of follicles and CL, the ovaries of all cows were scanned once a day throughout the experimental period (from the initial day of synchronization until next spontaneous ovulation) using real-time ultrasonography. The cross-sectional areas (mm^2^) of the dominant follicle (DF) and the luteal tissue were then determined using the following formula: Elliptical area = π (π equal 3.14) × (diameter a/2) × (diameter b/2), and the total CL cross-sectional area per cow was calculated by summation of the CL cross-sectional area (CL c-s area) in both ovaries.

Experiment 2
------------

[Fig. 2](#F2){ref-type="fig"} shows the protocol of Experiment 2. This study was conducted to examine the effect of day 6 injection of GnRH analogue in two estrus synchronization methods on the pregnancy rate of Japanese black cows. To accomplish this, a total of 41 multiparous Japanese black cows were randomly assigned into the same three experimental groups used in experiment 1 and then inseminated 16 to 20 h after the 2nd GnRH analogue injection. Rectal palpation was then conducted on day 45 to determine if the cows were pregnant. Experiment 2 was conducted at three private beef cattle farms located near our laboratory in Kagoshima prefecture. All cows were housed in tie-stalls.

Statistical analysis
--------------------

ANOVA (Dunnett\'s method) was used to determine if the P~4~ concentrations and CL c-s areas differed between the treatment groups and the control group. In addition, the differences in the CL c-s areas as a result of the different size of the dominant follicles were evaluated using ANOVA (Sheffe\'s test for multiple comparison). Finally, a student\'s t test was used to compare the diameters of the dominant follicles among groups on day 0 and one day before the next spontaneous ovulation, and the pregnancy rate among different groups on day 45 was compared using the χ square test. For all tests, a *p*-value of less than 0.05 was considered to be statistically significant.

Results
=======

Experiment 1
------------

All cows ovulated within 3 to 5 days of administration of the 1st or 2nd injection of the PGF analogue. Ovulation of the DF after administration of the 1st GnRH analogue to the cows synchronized using PGF occurred in 75% of cows in the control group, 50% of the cows in the Ovsynch + GnRH group and 100% of cows in the Ovsynch + CIDR + GnRH group. In contrast, ovulation following a 2nd GnRH analogue injection that was administered 9 days after the 1st GnRH injection occurred in 100% of cows in all three groups. In addition, the Ovsynch + GnRH group and the Ovsynch + CIDR + GnRH group ovulated and formed an accessory CL after administration of the 3rd GnRH analogue on day 6. Furthermore, a small CL was formed after induced ovulation of a small DF (less than 10 mm in diameter), regardless of the synchronization method used. Conversely, a large CL was formed after induced ovulation of a large DF (greater than 13 mm in diameter). As shown in [Fig. 3](#F3){ref-type="fig"}, there is a positive correlation between the cross-sectional area of the DF one day before ovulation and the cross-sectional area of luteal tissue on day 12. The DF of each group has been classified into one of the following groups based on its size: large (\>13 mm), medium (\<13 mm \>11 mm), and small (\<11 mm). The correlation between DF size one day prior to ovulation and the CL cross-sectional area on day 12 (mature CL) was 0.96.

[Fig. 4](#F4){ref-type="fig"} shows the P~4~ concentrations for all groups. The mean P~4~ concentration was higher in cows in the Ovsynch + GnRH group and the Ovsynch + CIDR + GnRH group, which had the accessory CL, than in cows in the control group. In addition, the P~4~ concentrations in the Ovsynch + CIDR + GnRH group were significantly higher than the concentrations in the control group from day 10 to day 21 (*p* \< 0.05). Finally, the P~4~ concentrations in the Ovsynch + GnRH group were significantly higher than the concentrations in the control group on days 11, 12, 17, and 18 (*p* \< 0.05).

The P~4~ concentration was found to positively correlated with the total cross-sectional area of the CL in all groups, with correlation coefficients of 0.89, 0.95 and 0.87 being observed for the Ovsynch + GnRH group, the Ovsynch + CIDR + GnRH group and the control group, respectively ([Figs. 5A, B and C](#F5){ref-type="fig"}). In addition, there was a significant difference in the cross-sectional area of luteal tissue in the control and treatment groups from days 12 to 22. Finally, as shown in [Fig. 6](#F6){ref-type="fig"}, there was no difference in the cross-sectional area of the luteal tissue between the Ovsynch + GnRH group and the Ovsynch + CIDR + GnRH group.

The length of the estrous cycle in one of the ovulating cows in the Ovsynch + CIDR + GnRH group was extended to 24 days, while the cycle of another cow in the same group was extended to 25 days. Cows that ovulated spontaneously in the cycle following the Ovsynch treatment had a larger-diameter DF than was observed during the Ovsynch synchronization period for all groups ([Table 1](#T1){ref-type="table"}); however, this difference was not statistically significant.

Experiment 2
------------

There was no difference in the conception rate among the three treatment groups (*p* \> 0.23). The pregnancy rate was 80% (8/10), 58.8% (10/17) and 57.1% (8/14) for the Ovsynch + GnRH group, the Ovsynch + CIDR + GnRH group, and the control group, respectively.

Discussion
==========

This study was designed to examine the effects of treatment with GnRH analogue 6 days after ovulatory synchronization by Ovsynch-based treatments on the pregnancy rate in postpartum multiparous Japanese black cows.

Many studies have reported a relationship between ovarian dynamics, hormonal concentrations and fertility following application of ovulatory synchronization methods. In a study that evaluated ovulatory synchronization methods that did not use an exogenous progesterone source, the P~4~ concentration prior to estrus synchronization was found to be lower in some cows \[[@B22]\]. In addition, a positive correlation between P~4~ concentration during the pre-insemination luteal phase and the conception rate has previously been reported \[[@B21]\]. Furthermore, it has been reported that a suboptimum P~4~ concentration combined with an increasing luteinizing hormone (LH) pulse frequency can induce ovulation of premature oocytes (relatively small ovulatory follicle) \[[@B18]\]. This can affect the embryo quality \[[@B1],[@B18]\], thereby inducing the premature release of PGF~2α~ in the subsequent cycle \[[@B24]\] and negatively affecting fertility.

In this study, a small ovulatory follicle (physiologically immature) resulted in formation of a small CL following induced ovulation. Such a small CL, in turn, resulted in the production of a lower concentration of progesterone than occurs when a normal CL is present \[[@B18]\]. This lower concentration is insufficient to maintain pregnancy in many cases \[[@B15]\]. In addition, it is believed that the low P~4~ concentration that is observed after insemination is associated with uterine secretion of PGF~2α~, which may interfere with maternal recognition of pregnancy and result in embryo loss \[[@B24]\].

In the present study, ovulation occurred in 100% of the cows that received both the 2nd and 3rd GnRH injections. This result may have been due to the injection of Buserelin (a potent GnRH analogue designed to induce the release of LH and FSH) and injection at the optimum time \[[@B4]\]. These results agree with the results of previously conducted studies that found a single dose of GnRH agonist administered on day 6 is capable of inducing ovulation, thereby leading to the formation of an accessory CL \[[@B11]\].

The cross-sectional area of the ovulatory follicle one day before ovulation was found to be positively correlated with the maximum cross-sectional area of the CL that was subsequently formed and the P~4~ concentration, regardless of the ovulation synchronization methods used. This is consistent with the results of a previously conducted study that reported formation of small CL after ovulation of small dominant follicle \[[@B28]\].

It has been reported that pulsatile LH secretion is responsible for early CL development in cows between days 2 and 12, and that this is required for normal progesterone production to occur \[[@B19]\]. In addition, Fraser et al. \[[@B8]\] reported that the most intense angiogenesis of the newly formed CL occurred during the early luteal phase in all mammals, and that this was primarily regulated by LH. Furthermore, Dhali et al. \[[@B5]\] showed that the early stages of CL development continued until days 5 to 6 of the estrous cycle, while a fully functional CL existed approximately at the mid-estrous cycle in Mithun cows (*Bos frontalis*). These findings suggest that a greater basal LH concentration and frequent low amplitude LH pulses facilitate early CL development. Finally, the results of studies conducted to evaluate ewes indicated that the luteal weight is reduced in the absence of LH support, which leads to a low P~4~ concentration \[[@B9]\].

In the present study, the post ovulation P~4~ concentration in the Ovsynch + CIDR + GnRH group tended to be higher than that of the Ovsynch + GnRH group. This may suggest that the rise in the P~4~ concentration occurred due to the presence of a sufficient concentration of LH following ovulation, and that this was caused by a high pre-ovulatory P~4~ concentration induced by the Ovsynch + CIDR + GnRH treatment.

In the present study, it was clearly demonstrated that the increased P~4~ concentration in the Ovsynch + GnRH group and the Ovsynch + CIDR + GnRH group was primarily due to the increased cross-sectional area of the luteal tissue, which resulted from the formation of an accessory CL following the day 6 GnRH analogue injection.

Many studies have been conducted to elucidate the relationship between day 5 or 6 post-insemination injection of GnRH analogue and the increase in conception rate. Some of these studies have found a negative correlation in cows \[[@B2],[@B11]\] and buffalo \[[@B3]\], while others have reported a positive correlation in heat stressed cows \[[@B30]\]. The results of the present study indicate that treatment with GnRH analogue on day 6 in cows synchronized by Ovsynch or Ovsych + CIDR and then subjected to Timed AI (TAI) had no effect on the pregnancy rate. However, these results also suggest that this treatment can maintain the rate of pregnancies at levels higher than 55%.

In conclusion, treatment with GnRH analogue on day 6 after ovulation synchronization using Ovsynch or Ovsych + CIDR increases in the plasma progesterone concentration when compared to controls. This effect was likely due to an increased the total area of luteal tissue that was generated as a result of the formation of an accessory CL. However, these changes did not improve the pregnancy rate in Japanese black cows.

We are grateful to the staff of the IRIKI farm of Kagoshima University and the students at the theriogenology laboratory of Kagoshima University for their help and assistance. In addition, we thank Professor Taya at the Tokyo University of Agriculture and Technology for his donation of progesterone antisera, and Professor Okamoto of Kagoshima University for his assistance in the data analysis.

![Experiment 1 protocol. All cows were pre-synchronized using single or double intra muscular injection of prostaglandin F~2α~ analogue 11 days apart. Next, 12 cows were randomly allocated into three experimental groups. Ovsynch synchronization was then induced 8 ± 1 days after the last PGf~2α~ injection. The cows in group 1 (Ovsynch + GnRH) were synchronized with Ovsynch followed by injection of 100 µg of GnRH analogue on day 6 (the day on which the 2nd GnRH analogue injection of Ovsynch protocol was administered was considered to be day 0). The cows in group 2 (Ovsynch + CIDR + GnRH) were synchronized with Ovsynch + CIDR followed by injection of 100 µg of GnRH analogue on by day 6. The remaining cows (Control) were synchronized with Ovsynch followed by injection with physiological saline (placebo) on day 6. All cows were monitored daily by real time ultrasonography until the next estrus. In addition, blood samples were collected daily from the time at which Ovsynch treatment began until ovulation in the first estrous cycle following the administration of Ovsynch. PGF; prostaglandin F~2α~. GnRH; gonadotropin releasing hormone. CIDR; controlled internal drug-release.](jvs-9-273-g001){#F1}

![Experiment 2 protocol. Multiparous Japanese black cows (n = 41) were randomly assigned into the three experimental groups (Ovsynch, Ovsynch + GnRH, and Ovsynch + CIDR + GnRH) that are described in the experiment 1 protocol, and then inseminated 16 to 20 h after receiving the 2nd GnRH analogue injection (day 0). On day 45, the cows were evaluated by palpation of the rectum to determine if they were pregnant.](jvs-9-273-g002){#F2}

![Cross-sectional area of dominant Follicles (DF) of different size and the cross-section area of the subsequently formed corpus luteum (CL). Values shown are the mean ± SD. Letters (a, b) and (a, c) on the same day indicate a statistical difference (*p* \< 0.05). The DF at one day before ovulation was assigned to one of the following 3 categories based on its diameter, regardless of the group it was from: large (\>13 mm), medium (\<13 mm \>11 mm), and small (\<11 mm).](jvs-9-273-g003){#F3}

![Progesterone (P~4~) concentration of the control (Ovsynch) and experimental groups (Ovsynch + GnRH, and Ovsynch + CIDR + GnRH). Values shown are mean ± SD. Letter (a,b) indicates the value is significantly different from (c) (*p* \< 0.05) on the same day.](jvs-9-273-g004){#F4}

![(A) Corpus luteum (CL) cross-sectional area (c-s area) and progesterone concentration of the control group (Ovsynch). Values are the mean ± SD. The progesterone (P~4~) concentration was positively correlated with the cross-sectional area of CL (*r* = 0.87). (B) Summation of the CL cross-sectional area (2 CL) and progesterone concentration of the Ovsynch + GnRH group. Values are the mean ± SD. The progesterone (P~4~) concentration was positively correlated with the cross-sectional area of the CL (*r* = 0.89). (C) Summation of the CL cross-sectional area (2 CL) and the progesterone concentration of the Ovsynch + CIDR + GnRH group. Values are the mean ± SD. The progesterone (P~4~) concentration was positively correlated with the cross-sectional area of the CL (*r* = 0.95).](jvs-9-273-g005){#F5}

![Cross-sectional area of the corpus luteum (CL) from the control (Ovsynch) and experimental groups (Ovsynch + GnRH, and Ovsynch + CIDR + GnRH). Value are the mean ± SD. (a, b) differ significantly from (c) from day 11 to day 23 (*p* \< 0.05).](jvs-9-273-g006){#F6}

###### 

Comparison of dominant follicle diameters following induced and spontaneous ovulation

![](jvs-9-273-i001)

Dominant follicle diameter on day 1 in cows subjected to Ovsynch based ovulatory synchronization (DF1), and in the next estrous cycle (spontaneous ovulation; DF2). No statistical difference was observed among groups. GnRH; gonadotropin releasing hormone. CIDR; controlled internal drug-release.
